Diabetes Mellitus, Type 2: all 9,590 studies

Page 25 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.

• Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy SubjectsCompletedNCT01473953Phase 1Results posted
• DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 DiabetesCompletedNCT01472432Phase 4Results posted
• Beta-Cell Dysfunction and Insulin Resistance Among Italian Patients With Type 2 Diabetes (MK-0000-113)CompletedNCT01472341Results posted
• Ranolazine Monotherapy in Subjects With Type 2 Diabetes MellitusCompletedNCT01472185Phase 3Results posted
• A 2-week Trial Of PF-04991532 In Patients With Type 2 DiabetesCompletedNCT01469065Phase 1Results posted
• A Study in Participants With Type 2 Diabetes MellitusCompletedNCT01468987Phase 3Results posted
• A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01468181Phase 3Results posted
• A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of UseCompletedNCT01464346Not applicableResults posted
• Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)CompletedNCT01462266Phase 3Results posted
• Shiga Microalbuminuria Reduction Trial-2CompletedNCT01461499Phase 4Results posted
• ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?CompletedNCT01460446Not applicableResults posted
• A Study on the Effects of LY2409021 on the Electrical Impulses of the HeartCompletedNCT01460368Phase 1Results posted
• A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female ParticipantsCompletedNCT01458210Phase 1Results posted
• Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 DiabetesCompletedNCT01456195Phase 3Results posted
• An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes PatientsTerminatedNCT01453049Phase 3Results posted
• Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes MellitusCompletedNCT01451398Phase 3Results posted
• Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes MellitusCompletedNCT01449747Phase 4Results posted
• Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic ControlCompletedNCT01438814Phase 4Results posted
• A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy ParticipantsCompletedNCT01436201Phase 1Results posted
• A Study in Patients With Type 2 Diabetes MellitusCompletedNCT01435616Phase 3Results posted
• A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneCompletedNCT01434186Phase 3Results posted
• A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy ParticipantsCompletedNCT01432938Phase 1Results posted
• Effect Of Exenatide Treatment on Liver Fat Content in Patients With DiabetesCompletedNCT01432405Phase 4Results posted
• Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 DiabetesCompletedNCT01427920Phase 4Results posted
• Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable AnginaCompletedNCT01425359Phase 4Results posted
• Diet and Systemic InflammationCompletedNCT01424306Not applicableResults posted
• Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes PatientsCompletedNCT01422876Phase 3Results posted
• A Study in Adults With Type 2 DiabetesCompletedNCT01421459Phase 3Results posted
• Pharmacogenetics of Ace Inhibitor-Associated AngioedemaCompletedNCT01413542Not applicableResults posted
• Efficacy and Safety Study of TA-7284 in Patients With Type 2 DiabetesCompletedNCT01413204Phase 3Results posted
• Vitamin D Supplementation on Cardiovascular Risk FactorsCompletedNCT01412710Not applicableResults posted
• Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 DiabetesCompletedNCT01409239Phase 4Results posted
• A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)CompletedNCT01409213Results posted
• A Study of LY2189265 and Sitagliptin in Participants With Type 2 DiabetesCompletedNCT01408888Phase 1Results posted
• The I-KAN Study: Internet Insulin Education for KansansCompletedNCT01408628Not applicableResults posted
• A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)CompletedNCT01407276Phase 1Results posted
• Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes MellitusCompletedNCT01406717Phase 3Results posted
• Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without PottasiumCompletedNCT01404078Not applicableResults posted
• An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 DiabetesCompletedNCT01400971Results posted
• Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 DiabetesCompletedNCT01396187Phase 1Results posted
• A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic PatientsCompletedNCT01396161Phase 1Results posted
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)CompletedNCT01394952Phase 3Results posted
• Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 DiabetesCompletedNCT01394510Not applicableResults posted
• Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and SulfonylureaCompletedNCT01392677Phase 3Results posted
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesCompletedNCT01392573Phase 3Results posted
• Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminCompletedNCT01388361Phase 3Results posted
• Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes MellitusCompletedNCT01387737Phase 3Results posted
• Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin TabletCompletedNCT01383356Phase 1Results posted
• Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic PatientsCompletedNCT01382303Phase 4Results posted
• Changes in Bone Turnover With Exposure to a GLP-1 Receptor AgonistTerminatedNCT01381926Phase 4Results posted
• A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a SulphonylureaCompletedNCT01381900Phase 3Results posted
• Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 DiabetesCompletedNCT01378117Phase 4Results posted
• Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes MellitusCompletedNCT01377844Phase 2Results posted
• Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on MetforminCompletedNCT01376557Phase 2Results posted
• A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With MetforminCompletedNCT01376323Phase 2Results posted
• Changes in Bone Turnover With Increased Incretin Hormone ExposureTerminatedNCT01374568Phase 4Results posted
• Technology-assisted Case Management in Adults With Type 2 DiabetesCompletedNCT01373489Not applicableResults posted
• Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)CompletedNCT01373450Phase 1Results posted
• Safety and Efficacy of Long Limb Roux-en Y ReconstructionCompletedNCT01373346Not applicableResults posted
• 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT01370005Phase 3Results posted
• Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes MellitusCompletedNCT01368081Phase 3Results posted
• Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing RegimensCompletedNCT01365507Phase 3Results posted
• Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-BrazilCompletedNCT01365091Phase 1Results posted
• Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 DiabetesCompletedNCT01364584Not applicableResults posted
• Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes MellitusCompletedNCT01364428Phase 3Results posted
• Effect of Dialysis Glucose Bath on Glycemic Control in Hemodialysis (HD)CompletedNCT01359904Not applicableResults posted
• A Study of LY2881835 in Healthy People and People With DiabetesCompletedNCT01358981Phase 1Results posted
• Pharmacokinetics/Pharmacodynamics of AlbiglutideCompletedNCT01357889Phase 2Results posted
• A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)TerminatedNCT01357148Results posted
• An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)CompletedNCT01357135Results posted
• A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)CompletedNCT01354990Results posted
• Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in HumansCompletedNCT01354977Phase 2Results posted
• The Effects of Glycemic Optimization Before Gastric Bypass SurgeryCompletedNCT01353118Not applicableResults posted
• The Relationship of Hemoglobin A1c and Diabetic Wound HealingTerminatedNCT01350102Phase 4Results posted
• Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 DiabetesCompletedNCT01342484Phase 2Results posted
• Continuous Glucose Monitoring (CGM) in Subjects With Type 2 DiabetesCompletedNCT01341067Results posted
• Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)CompletedNCT01340768Phase 3Results posted
• An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin MonotherapyCompletedNCT01340664Phase 2Results posted
• Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 DiabetesCompletedNCT01338870Phase 2Results posted
• Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes MellitusCompletedNCT01336738Phase 2Results posted
• Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01336023Phase 3Results posted
• Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 UnitsTerminatedNCT01334606Not applicableResults posted
• Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 DiabetesCompletedNCT01334229Phase 3Results posted
• Long-term Study of KAD-1229 in Type 2 Diabetes PatientsCompletedNCT01333592Phase 3Results posted
• Avandamet Bioequivalence Study Brazil - Fed AdministrationCompletedNCT01332071Phase 1Results posted
• Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes MellitusCompletedNCT01326026Phase 3Results posted
• A Study of the Effect of LY2189265 on Two Blood Pressure DrugsCompletedNCT01324388Phase 1Results posted
• Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in JapanCompletedNCT01318135Phase 2/3Results posted
• Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanCompletedNCT01318122Phase 2/3Results posted
• Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in JapanCompletedNCT01318109Phase 2/3Results posted
• Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in JapanCompletedNCT01318083Phase 2/3Results posted
• Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanCompletedNCT01318070Phase 2/3Results posted
• Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes MellitusCompletedNCT01316341Phase 1Results posted
• Home Exercise to Enhance Mobility for Older DiabeticsCompletedNCT01308008Not applicableResults posted
• Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes MellitusCompletedNCT01306214Phase 3Results posted
• Long-term Safety Study of MP-513 in Patients With Type 2 DiabetesCompletedNCT01301833Phase 3Results posted
• Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult FemalesCompletedNCT01301456Phase 1Results posted
• A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.CompletedNCT01301092Phase 1Results posted
• Effect of LY2189265 on Insulin Secretion in Response to Intravenous GlucoseCompletedNCT01300260Phase 1Results posted
• A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes PatientsCompletedNCT01298518Phase 1Results posted

← Diabetes Mellitus, Type 2 overview